These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 2474844

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Indications for interferon therapy in hepatology].
    Eisenburg J.
    Fortschr Med; 1993 Apr 10; 111(10):157-9. PubMed ID: 7684014
    [No Abstract] [Full Text] [Related]

  • 23. Hepatitis B virus precore/core variation and interferon therapy.
    Fattovich G, McIntyre G, Thursz M, Colman K, Giuliano G, Alberti A, Thomas HC, Carman WF.
    Hepatology; 1995 Nov 10; 22(5):1355-62. PubMed ID: 7590647
    [Abstract] [Full Text] [Related]

  • 24. Interferon therapy in chronic hepatitis B.
    Lancet; 1976 Nov 20; 2(7995):1122-3. PubMed ID: 62954
    [No Abstract] [Full Text] [Related]

  • 25. Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance.
    Lok AS, Akarca US, Greene S.
    Hepatology; 1995 Jan 20; 21(1):19-24. PubMed ID: 7528709
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Influence of genetic factors on the susceptibility to HBV infection, its clinical pictures, and responsiveness to HBV vaccination.
    Kacprzak-Bergman I, Nowakowska B.
    Arch Immunol Ther Exp (Warsz); 2005 Jan 20; 53(2):139-42. PubMed ID: 15928582
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Interferon in the treatment of virus diseases].
    Abb J.
    Internist (Berl); 1983 Nov 20; 24(11):627-31. PubMed ID: 6197388
    [No Abstract] [Full Text] [Related]

  • 30. Hepatitis B viral infection.
    Thomas HC.
    Am J Med; 1988 Aug 29; 85(2A):135-40. PubMed ID: 3136648
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
    Suzuki Y, Kobayashi M, Ikeda K, Suzuki F, Arfase Y, Akuta N, Hosaka T, Saitoh S, Kobayashi M, Someya T, Matsuda M, Sato J, Watabiki S, Miyakawa Y, Kumada H.
    J Med Virol; 2005 May 29; 76(1):33-9. PubMed ID: 15779048
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Treatment of chronic viral hepatitis B and C].
    Stránský J.
    Vnitr Lek; 1997 Jan 29; 43(1):41-4. PubMed ID: 9221566
    [No Abstract] [Full Text] [Related]

  • 37. [Interferon therapy in chronic active viral hepatitis].
    Lengyel G, Fehér J.
    Orv Hetil; 1995 Jan 01; 136(1):3-7. PubMed ID: 7531317
    [Abstract] [Full Text] [Related]

  • 38. Interferon therapy for hepatitis B and C.
    Murray JA.
    Postgrad Med; 1998 Dec 01; 104(6):25, 28. PubMed ID: 9861254
    [No Abstract] [Full Text] [Related]

  • 39. Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan.
    Kobayashi M, Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Suzuki F, Akuta N, Someya T, Matsuda M, Sato J, Takagi K, Miyakawa Y, Kumada H.
    J Med Virol; 2002 Dec 01; 68(4):522-8. PubMed ID: 12376960
    [Abstract] [Full Text] [Related]

  • 40. [Predictive factors of response to interferon in chronic hepatitis].
    Forns X, Ampurdanés S.
    Gastroenterol Hepatol; 1995 Dec 01; 18(7):388-95. PubMed ID: 7553278
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.